Emiliem, Inc. produces novel oncology therapeutics. It also focuses on inflammatory and metabolic diseases.

Dynavax is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through toll-like receptor (TLR) stimulation.

Emiliem, Inc is a private biotechnology company currently focused on all aspects of the drug discovery and development process

Dohmen is a life science services company dedicated to creating a safer, more effective healthcare supply system. As the trusted partner to more than 700 BioPharma and MedTech innovators, Dohmen propels start-up, mid-tier and Fortune 500 companies with support services that span the commercialization continuum from pre-approval regulatory consulting to in-home patient services. Privately held…

Correlia Biosystems is creating next generation proteomic technology that integrates complex assays such as ELISA or other immunoassays into rapid, automated and portable platforms for pharma and diagnostic use.

Channel strives to develop easy-to-use, safe, and cost-effective medical devices, resulting in exceptional outcomes and superior patient comfort that are accessible to all women.

Celgene Corporation is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

Cell Design Labs is a biotherapeutics company pioneering breakthrough science to develop disruptive cell-based therapies for cancer and other devastating diseases.

rystalGenomics is a leading structural chemoproteiomics-based drug discovery and development company headquartered in Seoul, Korea with a US presence (CG Pharmaceuticals, Inc.) in Emeryville, California for multi-national clinical management.

Cellular Engineering Tools (CRISPR) Genome editing to develop medical therapies and bio-based products